FLAGYL 125 mg/5 ml, oral suspension bottle, 120 ml
Active ingredients: Metronidazole, Metronidazole benzoate
Commercialized according to BDPMDispensing in France: Prescription only
Oral suspensionbottle, 120 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FLAGYL 125 mg/5 ml, suspension buvable
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre de 120 ml avec fermeture de sécurité enfant et avec cuillère-mesure
- Marketing authorisation holder
- LABORATOIRES FIDIA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jul 1972
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65020253CIP73131694CIP133400931316947Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTRONIDAZOLE (BENZOATE DE)suspension | 4,0 g · 100 ml | SA |
| MÉTRONIDAZOLEsuspension | 2,5 g · 100 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.